1. Aitken CK, Kerger M, Crofts N, Peer-delivered hepatitis C testing and counselling - a means of improving the health of injecting drug users. Drug and Alcohol Review. 2002 21(1):33-38
  2. Anti Discrimination Board of NSW. C change: Report of the enquiry into hepatitis C related discrimination. NSW Attorney General’s Department. Sydney NSW 2001. Available at http://www.agd.nsw.gov.au/lawlink/adb/ll_adb.nsf/pages/adb_hepatitis_c_enquiry
  3. Australian Bureau of Statistics. 2003. Prisoners in Australia. ABS, Canberra, ACT.
  4. Australian Government Department of Health and Aged Care. Models of Care for the Management of Hepatitis C Infection in Adults. Canberra: Commonwealth Department of Health and Aged Care. 2003.
  5. Australian Immunisation Handbook, 8th Edition Australian Technical Advisory Group on Immunisation 2003
  6. Australian Injecting and Illicit Drug Users League (AIVL). 2006. A framework for peer education by drug-user organisations. Canberra: Australian Injecting and Illicit Drug Users League.
  7. Australian National Council on Drugs. Needle and Syringe Programs: Position Paper. 2002. Canberra: Australian National Council on Drugs.
  8. Australian National Council on AIDS, Hepatitis C and Related Diseases. 2001. Guidelines on HIV/Hepatitis and Other Blood Borne Viruses in Sport. Bulletin 19. June 2001.
  9. Betteridge G. Harm reduction in prisons and jails: International experience. 2005. Canadian HIV/AIDS Legal Network, Canada.
  10. Black, E, Dolan K and Wodak, A. 2004. Supply, Demand and Harm Reduction Strategies in Australian Prisons. Australian National Council on Drugs: Research Paper No 9. Australian National Council on Drugs, Canberra, ACT.
  11. Boonwaat L, Haber P, Levy M et al. A review of the outcomes of hepatitis C treatment in New South Wales [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  12. Butler, T, Boonwaat L and Hailstone S. 2005. National Prisons Entrants' Blood Borne Virus Survey Report, 2004. Centre for Health Research in Criminal Justice and National Centre for HIV Epidemiology and Clinical Research, University of NSW, Sydney.
  13. Butler T, Levy M, Dolan K et al. Drug use and its correlates in an Australian prisoner population. Addiction research and Theory 2003 11(2):89-101
  14. Butler T.G, Dolan KA, Ferson MJ et al. Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. MJA 1997 166:127-130.
  15. Butler, T and Milner, L. 2003a. The 2001 New South Wales Inmate Health Survey. New South Wales Corrections Health Service, Sydney.
  16. Centers for Disease Control and Prevention. HIV transmission between two adolescent brothers with haemophilia MMWR 1993, 42:948–951.

    Top of Page
  17. Communicable Diseases Network Australia. Australian Hepatitis C Surveillance Strategy. Sydney: NCHECR 1993. Available at "http://www.health.gov.au/internet/main/publishing.nsf/content/cda-pubs-cdi-2002-cdi2601-cdi2601d.htm
  18. Corrective Services Canada Safer Tattooing Practices Initiative: Guidelines, CSC, 2005
  19. Crofts N, Dore G & Locarnini S. Hepatitis C: an Australian Perspective. 2001. IP Publishing Melbourne.
  20. Crofts, N. A cruel and unusual punishment. MJA 1997 166:116.
  21. Crofts N, Thompson S, Kaldor J. Epidemiology of the hepatitis C virus in Australia. Technical report No 3. May 1999. Commonwealth Department of Health and Ageing. Canberra.
  22. Daly P. Hepatitis C and the British Columbia experience with hepatitis A vaccination. Journal of Viral Hepatitis. 2000 Supplement 7 (SUPPLEMENT 1):23-25
  23. Dolan, K. Can hepatitis C transmission be reduced in Australian prisons? MJA 2001. 174:378-379.
  24. Department of Health and Ageing. Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting. 2004 The Australian Government Department of Health and Ageing. Canberra ACT. Available at http://www.health.gov.au/internet/main/publishing.nsf/Content/icg-guidelines-index.htm
  25. Department of Health and Ageing. 2004. The National Drug Strategy Australia’s Integrated Framework: 2004-2009. Canberra: Commonwealth Department of Health and Ageing. Available at http://www.nationaldrugstrategy.gov.au/
  26. Department of Health and Ageing. 2005. National Hepatitis C Strategy 2005-2008. Canberra: Commonwealth Department of Health and Ageing.
  27. Department of Health and Ageing. National HIV testing policy. 2006. Canberra: Commonwealth Department of Health and Ageing. (in draft)
  28. Department of Health and Ageing. National Hepatitis C testing policy. 2006a. Canberra: Commonwealth Department of Health and Ageing. (in draft)
  29. Devilly G, Sorbello L, Eccleston L et al. Prison based peer-education schemes - review article. Aggression and violent behaviour. 2005 10(2):219-240
  30. Dolan K. The epidemiology of hepatitis C infection in prison populations. Canberra, Commonwealth Department of Health and Aged Care, 2000.

    Top of Page
  31. Dolan, K., Wodak, A., Hall, W. A bleach program for inmates in NSW: An HIV prevention strategy. Australian and New Zealand Journal of Public Health. 1998 22:838-840.
  32. Dolan K. Surveillance and prevention of hepatitis C in Australian prisons: a discussion paper. Technical report #95, 2000. 2000 Sydney: National Drug & Alcohol Research Centre.
  33. Dolan K, White B, Shearer J et al. Methadone maintenance treatment reduces mortality, re-incarceration and hepatitis C among inmates [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  34. Dolan K, Hall W, Wodak A. Methadone maintenance reduces injecting in prison. BMJ 1996 312(7039):1162
  35. Dolan KA, Wodak A and Hall WD, Methadone Maintenance Treatment Reduces Heroin Injection in New South Wales Prisons. Drug and Alcohol Review 1998 17:153-158
  36. Dore, G. & Sasadeusz, J. 2005. Co-infection: HIV and Viral Hepatitis: a guide for clinical management. Australasian Society for HIV Medicine, Sydney, Australia.
  37. Drug and Alcohol Medical Teaching Project. A NSW Department of Health and University of Sydney Collaboration 2005.
  38. Ferson MJ, Young LC, Stokes ML. Changing epidemiology of hepatitis A in the 1990s in Sydney, Australia. Epidemiology & Infection. 1998 121:631-6
  39. French MA; Herring BL; Kaldor JM et al. Intrafamilial transmission of HIV-1 infection from individuals with unrecognized HIV-1 infection. AIDS. 2003. 17(13):1977-1981.
  40. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection. NEJM. 2002. 347:975–982
  41. Haber PS, Parsons, SJ, Harper SE et al. Transmission of hepatitis C within Australian Prisons. MJA 1999 171:31-33
  42. Hadziyannis, SJ et al. 2004. Chronic Hepatitis C: A randomised study of treatment duration and ribavirin dose. Annals of international Medicine Vol 140 No.5: pp346-357.
  43. Hallinan R, Byrne A, Agho K et al. Referral for chronic HCV treatment among patients on opioid replacement therapy [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  44. Heale P, Wallis J, Swan A, Alberti S. 2003. Survey of harms in Victorian Prisons. Turning Point Alcohol and Drug Centre Inc. Melbourne, Australia.
  45. Health Outcomes International, National Centre in HIV Epidemiology and Clinical Research, Drummond, M. 2002. Return on investment in needle and syringe programs in Australia: Summary report. Canberra: Commonwealth Department of Health and Ageing.

    Top of Page
  46. Hellard M et al. The prevalence and risk factors associated with the transmission of hepatitis C virus in Australian Correctional facilities. Epidemiology and Infection 2004 132:409-415
  47. Hepatitis C Council NSW factsheet - www.hepatitisc.org.au
  48. Hepatitis C Virus Projections Working Group. 2006. Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006. National Centre in HIV Epidemiology and Clinical Research Darlinghurst, NSW.
  49. Holly,C (2001 Review of the literature on injecting drug use within urban indigenous communities. Aboriginal Drug and Alcohol Council.
  50. King R. Sexual behavioural change: where have the theories taken us? UNAIDS. Geneva. 1999.
  51. Kolor B. Patient education and treatment strategies implemented at a pharmacist managed hepatitis c virus clinic. Pharmacotherapy 2005 25:1230-41
  52. Lines RR, Jürgens G, Betteridge H, et al. Prison Needle Exchange: Lessons from a comprehensive review of the international experience. Montreal: Canadian HIV/AIDS Legal Network. 2004
  53. Lloyd A. Enhancing hepatitis C prevention, treatment and care in prison populations [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  54. Miller, E., Bunting, S. Increased risk for HCV-seroconversion in a South Australian women's prison, in conjunction with the University of Adelaide. Paper presented at the 34th Public Health Association of Australia Annual Conference. 2002. Adelaide.
  55. Morbidity and Mortality Weekly Report (MMWR). 1993. 42(21):418-9. Use of bleach for disinfection of drug injection equipment.
  56. Mukherjee S. Ethnicity and crime: an Australian research study. 1999 Australian Institute of Criminology Canberra. Available at http://www.aic.gov.au/publications/ethnicity-crime/
  57. National Centre in HIV Epidemiology and Clinical Research. 2005. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report. National Centre in HIV Epidemiology and Clinical Research, the University of NSW, Sydney, NSW; Australian Institute of Health and Welfare, Canberra, ACT. Available at http://web.med.unsw.edu.au/nchecr/
  58. National Health and Medical Research Council. The Australian Immunisation Handbook. 8th ed.Canberra: Australian Government Publishing Service, 2003.
  59. National Public Health Partnership (NPHP). Regulation of Infection Control in the Body Art Industry in Australia and New Zealand. National Public Health Partnership. 2002. Available athttp://www.dhs.vic.gov.au/nphp/publications/legislation/bodyart.pdf
  60. Nelles J and Fuhrer A. Drug and HIV prevention at the Hindelbank penitentiary: Abridged report of the evaluation of the pilot project. Bern SFOPH, 1995

    Top of Page
  61. O'Sullivan B, Levy M, Dolan K et al. Hepatitis C transmission and HIV post-exposure prophylaxis after needle and syringe sharing in Australian prisons. MJA 2003 178(11):546-549
  62. Prison Officers Association of Australasia 2006. Personal correspondence to Prisons Working Group.
  63. Public Health Agency of Canada. The Effectiveness of Bleach in the Prevention of Hepatitis C Transmission - Final Report. 2004.
  64. Read V, Bevan J. Meeting the challenge of developing prison based hepatitis C and other blood-borne viruses education programs [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  65. Reddy KR. Public Health Impact, Natural History, Diagnosis and Clinical Management of Hepatitis C: Emerging Clinical Options with Interferon-based Therapies. Medscape, 2002
  66. Rutter, S, Dolan, K, Wodak, A, et al. Prison-Based Syringe Exchange: A Review of International Research and Program Development. 2001. Sydney: National Drug and Alcohol Research Centre.
  67. Sasadeusz J, Dore G, Kronberg I et al. Pegylated interferon alfa-2a plus ribavirin for patients with chronic hepatitis C on drug dependency treatment: interim analysis from the methadone study [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  68. Temple-Smith M, McNally SP. Considering treatment for hepatitis C [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  69. Thein HH, Krahn M, Kaldor J et al. Cognitive and mood effects of pegylated interferon alfa-2a and ribavirin combination therapy in HCV monoinfected and HIV/HCV coinfected individuals [abstract]. Presented at the 5th Australasian Viral Hepatitis Conference. Sydney. 2006
  70. Tumminelli F, Marcellin P, Rizzo S et al. Shaving as a potential source of hepatitis C virus infection. Lancet 1995, 345:658.
  71. US Department of Health and Human Services. Medical advice for persons who inject illicit drugs. HIV Prevention Bulletin. CDC; Health Resources and Services Administration; National Institute on Drug Abuse, National Institutes of Health; Substance Abuse and Mental Health Services Administration; May 1997. Available at http://www.cdc.gov/idu/pubs/hiv_prev.htm.
  72. Whiteman D, McCall B, Falconer A. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control. Journal of Viral Hepatitis. 1998 5(4):277-283
  73. World Health Organization. 1986 Ottawa Charter for Health Promotion. Presented at the First International Conference on Health Promotion, Ottawa, Canada. Available at http://www.who.int/hpr/NPH/docs/ottawa_charter_hp.pdf
  74. WHO Regional Office for Europe’s Health Evidence Network 2005. What is the evidence for the effectiveness of interventions to reduce hepatitis C infection and the associated morbidity?